• HPR

Accelerating the Development of a Malaria Vaccine

The research collaboration project, “Transmission-blocking Vaccine of Malaria” has been accepted by the Global Health Innovative Technology Fund’s product development program. Hamamatsu Pharma Research continues to challenge this new therapeutic field through a collaboration with University of Florida.

3 views0 comments

Recent Posts

See All

Korea Pharm & Bio 2021

HPR is virtually attending Korea Pharm & Bio 2021, May 25 - 28. Looking forward to presenting HPR's services there!

Follow us:

HPR ProudCROMember_Biocom

Copyright © HAMAMATSU PHARMA RESEARCH U.S.A., Inc All rights reserved.

Hamamatsu Pharma Research U.S.A., Inc (Business Development Office)

400 N Tustin Ave. Ste 240 Santa Ana, CA 92705

E-mail: info_us[at]